Patients achieving RBC transfusion independence.1
Give your patients the time to achieve transfusion benefit.1
Median increase in hemoglobina was 5.4 g/dL (1.1-11.4) in patients achieving transfusion independence.19
Durable response in patients treated with REVLIMID.1
MEDIAN DURATION OF RBC TRANSFUSION INDEPENDENCE AT INTERIM ANALYSIS.
Long-term duration of response.20
Cytogenetic response in del 5q MDS ± additional cytogenetic abnormalities evaluated in a non-interventional extension study.20